Investec says Rubicon’s R&D, capital allocation and acquisition strategy has created a ROI-led growth engine across its ...

Business commentators believe 2026 will see steady progression in AI usage, with it frequently absorbed into daily operations ...

While achieving AI ROI may not happen as quickly as some expected, I still believe AI will provide companies with a ...

In 2026, boards won’t ask if you use AI — they’ll ask if you truly understand, control, and can explain how it’s steering the ...

Bulk SMS allows companies to provide real-time transactional alerts like confirmation of orders, payment updates, and ...

Enterprise AI adoption surged in 2025, but scaling still lags. Explore 7 key enterprise AI adoption trends shaping 2026.

As 2026 gets underway, social media is entering an era where engagement matters more than ever, but not in the old sense of ...

Podcasts, pop-up experiences and high-touch engagements are just some of the ways modern coaches are reshaping the way they ...

A federal appeals court in the US has declined to overturn an attempt by Novartis to block the launch of a generic version of its blockbuster heart failure drug Entresto. The US Court of Appeals for ...

Lantheus has filed what it says is the first generic version of Novartis’ big-selling cancer radionuclide therapy Lutathera in the US, used to treat rare neuroendocrine tumours (NETs). The FDA has ...

Julia Kagan is a financial/consumer journalist and former senior editor, personal finance, of Investopedia. Lea Uradu, J.D., is a Maryland state registered tax preparer, state-certified notary public, ...